Concepedia

Sylwia Marshall

SM

Statistics

Publications

7

Citations

269

H-Index

7

Active since

2004

Affiliations

F-star (United Kingdom)(Current)

Sylwia Marshall is an author at F-star (United Kingdom) specializing in oncology, immunotherapy, and bispecific antibody therapy.

ORCID

Publications per year

2004–2022

7

Publications

7

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance

Leland J. Yee, Peter Kelleher, Robert Goldin et al. · Journal of Viral Hepatitis · 2004 · 69 citations

, , +17

FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models

Matthew A. Lakins, Alexander Koers, Raffaella Giambalvo et al. · Clinical Cancer Research · 2020 · 65 citations

, , +17

A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance

Timothy A. Yap, Patricia LoRusso, Deborah J. Wong et al. · Clinical Cancer Research · 2022 · 50 citations · Full text

, , +17

CD56+dim and CD56+bright cell activation and apoptosis in hepatitis C virus infection

Amy Lin, Stevan A. Gonzalez, S. Cunningham‐Rundles et al. · Clinical & Experimental Immunology · 2004 · 43 citations · Full text

, , +16

Phase 1 study of bispecific HER2 antibody-drug conjugate MEDI4276 in patients with advanced HER2-positive breast or gastric cancer

Mark D. Pegram, Erika Hamilton, Antoinette R. Tan et al. · Annals of Oncology · 2018 · 16 citations

, , +17

1–5 of 7